A novel gene mutation in PANK2 in a patient with severe jaw-opening dystonia

Zuhal Yapici1, Nihan Hande Akcakaya2, Pinar Tekturk1

  • 1Istanbul University, Istanbul Medical Faculty, Department of Neurology, Division of Child Neurology, Istanbul, Turkey.

Brain & Development
|May 18, 2016
PubMed

Insights

Pantothenate kinase-associated neurodegeneration (PKAN) is a rare brain disorder. This study details a PKAN case with severe jaw-opening dystonia, highlighting long-term outcomes and genetic findings.

Area of Science:

  • Neuroscience and Genetics
  • Rare Neurodegenerative Diseases

Background:

  • Pantothenate kinase-associated neurodegeneration (PKAN) is a rare, inherited neurodegenerative disorder.
  • Key features include dystonia, retinopathy, spasticity, and cognitive decline.
  • The "eye-of-the-tiger" sign on MRI aids in diagnosis.

Observation:

  • A 16-year-old male presented with severe, persistent jaw-opening dystonia.
  • This specific dystonia presentation showed limited response to conventional treatments.
  • The case highlights potential heterogeneous etiologies within PKAN.

Findings:

  • Presents long-term follow-up data for a PKAN patient with severe jaw-opening dystonia.
  • Includes detailed genetic analysis results for the described case.
  • Discusses the clinical course and treatment challenges associated with this PKAN phenotype.

Implications:

  • Enhances understanding of PKAN's diverse clinical presentations.
  • Informs differential diagnosis strategies for complex dystonia cases.
  • Suggests the need for tailored therapeutic approaches in PKAN management.

Related Concept Videos

Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
3.0K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
706